Founded and led by Franz Weiberth, SynDev Technologies provides cutting edge consulting in the synthesis and progression of pharmacologically active new small molecules from lab to clinic to commercial manufacturing. Based on 30+ years of experience and innovation, SynDev specializes in all things synthesis and development, including:
CMC strategy and coordination
Project progression, early development to clinic
Drugability assessments
Drafting regulatory documents to support INDs (Module 3)
Organic chemistry
Route scouting and optimization
Multi-step synthesis development
Process chemistry and scale up
Strategic sourcing
Analytics
Physical quality
Technology transfer
Due diligence
cGMPs
